Logo

Southeast Cancer Control Consortium, Inc.

Head and Neck Cancer

Protocol Number Study Title

CTSU E1305
A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer

RTOG 0421
A Phase III Trial for Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Reirradiation and Chemotherapy Versus Chemotherapy Alone

RTOG 0522
A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin Versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) [Followed by Surgery for Selected Patients] for Stage III and IV Head and Neck Carcinomas

RTOG 0537
Phase II closed 10/23/09
Phase III OPEN
A Phase II/III Study Comparing Acupuncture-like Transcutaneous Electrical Nerve Stimulation (ALTENS) Versus Pilocarpine in Treating Early Radiation-Induced Xerostomia

RTOG 0920
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab
for Locally-Advanced Resected Head and Neck Cancer
  2150 Country Club Road, Suite 200, Winston-Salem, NC 27104-4241
Phone: (336) 777-3036 Fax: (336) 777-3177 Email: scccinfo@wfubmc.edu
352,100 hits

Valid CSS!